Financial Architects (New Jersey)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $3.14M | Sell |
23,278
-272
| -1% | -$39.9K | 0.47% | 47 |
|
|
2023
Q1 | $3.75M | Sell |
23,550
-460
| -2% | -$70.3K | 0.6% | 36 |
|
|
2022
Q4 | $3.88M | Buy |
24,010
+66
| +0.3% | +$10.1K | 0.64% | 33 |
|
|
2022
Q3 | $3.21M | Sell |
23,944
-56
| -0.2% | -$8.04K | 0.56% | 40 |
|
|
2022
Q2 | $3.68M | Sell |
24,000
-1,492
| -6% | -$228K | 4.68% | 3 |
|
|
2022
Q1 | $4.13M | Buy |
25,492
+1,016
| +4% | +$148K | 0.59% | 39 |
|
|
2021
Q4 | $3.31M | Buy |
24,476
+865
| +4% | +$102K | 0.45% | 50 |
|
|
2021
Q3 | $2.55M | Buy |
23,611
+341
| +1% | +$39K | 0.37% | 66 |
|
|
2021
Q2 | $2.62M | Sell |
23,270
-123
| -0.5% | -$13.9K | 0.38% | 66 |
|
|
2021
Q1 | $2.53M | Buy |
23,393
+285
| +1% | +$30.5K | 0.4% | 59 |
|
|
2020
Q4 | $2.48M | Sell |
23,108
-271
| -1% | -$26K | 0.46% | 46 |
|
|
2020
Q3 | $2.05M | Buy |
23,379
+1,744
| +8% | +$164K | 0.45% | 52 |
|
|
2020
Q2 | $2.12M | Buy |
21,635
+3,172
| +17% | +$279K | 0.49% | 47 |
|
|
2020
Q1 | $1.41M | Sell |
18,463
-193
| -1% | -$16.4K | 0.39% | 57 |
|
|
2019
Q4 | $1.65M | Sell |
18,656
-915
| -5% | -$76K | 0.36% | 62 |
|
|
2019
Q3 | $1.48M | Sell |
19,571
-1,457
| -7% | -$99.9K | 0.35% | 63 |
|
|
2019
Q2 | $1.53M | Sell |
21,028
-377
| -2% | -$29.6K | 0.29% | 74 |
|
|
2019
Q1 | $1.73M | Sell |
21,405
-2,166
| -9% | -$177K | 0.29% | 68 |
|
|
2018
Q4 | $2.17M | Sell |
23,571
-1,184
| -5% | -$104K | 0.42% | 47 |
|
|
2018
Q3 | $2.34M | Sell |
24,755
-800
| -3% | -$75.9K | 0.38% | 50 |
|
|
2018
Q2 | $2.37M | Sell |
25,555
-915
| -3% | -$89.4K | 0.42% | 44 |
|
|
2018
Q1 | $2.51M | Buy |
26,470
+379
| +1% | +$41.6K | 0.49% | 35 |
|
|
2017
Q4 | $2.52M | Sell |
26,091
-937
| -3% | -$88.3K | 0.42% | 43 |
|
|
2017
Q3 | $2.4M | Sell |
27,028
-631
| -2% | -$48K | 0.43% | 43 |
|
|
2017
Q2 | $2.01M | Sell |
27,659
-21,950
| -44% | -$1.48M | 0.36% | 50 |
|
|
2017
Q1 | $3.23M | Buy |
49,609
+204
| +0.4% | +$12.8K | 0.57% | 36 |
|
|
2016
Q4 | $3.09M | Buy |
49,405
+119
| +0.2% | +$7.26K | 0.73% | 29 |
|
|
2016
Q3 | $3.11M | Sell |
49,286
-1,634
| -3% | -$106K | 0.83% | 26 |
|
|
2016
Q2 | $3.15M | Buy |
50,920
+6,216
| +14% | +$379K | 0.89% | 26 |
|
|
2016
Q1 | $2.55M | Buy |
44,704
+10,595
| +31% | +$591K | 0.91% | 24 |
|
|
2015
Q4 | $2.02M | Sell |
34,109
-312
| -0.9% | -$18K | 0.81% | 29 |
|
|
2015
Q3 | $1.87M | Buy |
34,421
+2,477
| +8% | +$161K | 0.79% | 29 |
|
|
2015
Q2 | $2.15M | Buy |
31,944
+15,017
| +89% | +$980K | 0.77% | 25 |
|
|
2015
Q1 | $991K | Sell |
16,927
-69
| -0.4% | -$4.17K | 0.38% | 54 |
|
|
2014
Q4 | $1.11M | Buy |
+16,996
| New | +$1.07M | 0.49% | 46 |
|
|
2014
Q3 | – | Sell |
-11,668
| Closed | -$659K | – | 877 |
|
|
2014
Q2 | $659K | Buy |
11,668
+97
| +0.8% | +$5.09K | 0.32% | 71 |
|
|
2014
Q1 | $595K | Buy |
11,571
+10
| +0.1% | +$505 | 0.36% | 71 |
|
|
2013
Q4 | $611K | Buy |
11,561
+1,201
| +12% | +$59K | 0.36% | 71 |
|
|
2013
Q3 | $463K | Buy |
10,360
+128
| +1% | +$5.67K | 0.3% | 72 |
|
|
2013
Q2 | $423K | Buy |
+10,232
| New | +$448K | 0.31% | 70 |
|
Other funds holding ABBV
Financial Architects (New Jersey)'s ABBV Position: Q2 2023 in Review
Financial Architects (New Jersey) reduced its AbbVie (ABBV) stake by 1.2% in Q2 2023, selling an estimated $39.9K and leaving 23,278 shares worth $3.14M. The position accounts for 0.47% of the portfolio, ranked #47.
Financial Architects (New Jersey) first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $4.13M in Q1 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.
- Financial Architects (New Jersey) held 23,278 shares of AbbVie worth $3.14M as of Q2 2023.
- Financial Architects (New Jersey) sold 272 AbbVie shares in Q2 2023, an estimated $39.9K.
- AbbVie made up 0.47% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #47 holding.
- Financial Architects (New Jersey) first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
- Financial Architects (New Jersey)'s AbbVie position peaked at $4.13M in Q1 2022.
- 3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.
Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.